CG
Caprock Group’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.23M | Buy |
145,411
+1,584
| +1% | +$24.3K | 0.07% | 265 |
|
|
2024
Q4 | $3.17M | Sell |
143,827
-1,543
| -1% | -$34K | 0.1% | 171 |
|
|
2024
Q3 | $2.62M | Buy |
145,370
+13,068
| +10% | +$235K | 0.1% | 183 |
|
|
2024
Q2 | $2.15M | Buy |
+132,302
| New | +$2.15M | 0.09% | 191 |
|
|
2020
Q1 | – | Sell |
-23,494
| Closed | -$230K | – | 415 |
|
|
2019
Q4 | $230K | Sell |
23,494
-236
| -1% | -$2.31K | 0.04% | 299 |
|
|
2019
Q3 | $163K | Buy |
23,730
+1,378
| +6% | +$9.47K | 0.03% | 328 |
|
|
2019
Q2 | $206K | Buy |
+22,352
| New | +$206K | 0.04% | 308 |
|
|
2017
Q4 | – | Sell |
-11,117
| Closed | -$196K | – | 493 |
|
|
2017
Q3 | $196K | Buy |
11,117
+997
| +10% | +$17.6K | 0.04% | 411 |
|
|
2017
Q2 | $336K | Buy |
10,120
+2,350
| +30% | +$78K | 0.07% | 253 |
|
|
2017
Q1 | $249K | Buy |
+7,770
| New | +$249K | 0.06% | 283 |
|
|
2016
Q4 | – | Sell |
-6,227
| Closed | -$287K | – | 394 |
|
|
2016
Q3 | $287K | Buy |
+6,227
| New | +$287K | 0.07% | 266 |
|
|
2016
Q2 | – | Sell |
-4,642
| Closed | -$248K | – | 348 |
|
|
2016
Q1 | $248K | Buy |
+4,642
| New | +$248K | 0.06% | 260 |
|